For nearly 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
An exciting opportunity exists for an Associate Director to lead the Edinburgh Client Services team. This is a key position within the site and also includes involvement in site-level discussions and decision-making as a member of the Edinburgh site’s Senior Leadership Team. The Associate Director reports directly to the Senior Director, Client Services Europe.
The Associate Director will manage a growing and expanding team of scientifically qualified, client-focused Client Managers at Charles River’s largest European site. The Associate Director will also ensure the delivery of high-quality commercial proposals to Charles River’s clients worldwide, providing a positive customer experience. On a daily basis, the Associate Director will be instrumental in making pricing and scheduling decisions, and liaising with key internal stakeholders to drive business growth through building strong client relationships. Providing input as part of European and global teams will also be a key aspect of this role.
This is an exciting role with opportunity to drive change management and process improvements.
- Management or direct supervisory experience
- Experience of working in a CRO or related industry and/or good knowledge and understanding of the CRO outsourcing process
- Strong leadership skills
- Strong customer focus
- Desired: strong scientific background, e.g. BSc in a Biological Sciences or related subject.
The salary for this position is dependent on skills and experience.
The closing date is 09 April 2021.
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3% to $1.68 billion from $1.36 billion in 2015.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~70% of the drugs approved by the FDA in 2016.
For more information, please visit www.criver.com.